ALPS Medical Breakthroughs ETF Rating $67.25 +0.33 (+0.49%) As of 03:58 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.73Holdings in SBIO have an aggregate rating of Moderate Buy based on 347 analyst ratings issued in the past year covering 25 companies (57.7% of the portfolio).SBIO Aggregate Price Target$66.78-0.18% DownsideHigh Prediction$66.78Average Prediction$66.78Low Prediction$66.78Holdings in SBIO have an aggregate price target of $66.78 and a range of $66.78 to $66.78 covering 25 companies (57.7% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.75%CRNXCrinetics Pharmaceuticals$84.68+0.3%1.9416 of 5 stars2.24$81.00 -4.3%17Positive News4.48%APGEApogee Therapeutics$134.56+0.1%1.0034 of 5 stars2.20$124.43 -7.5%20Earnings ReportAnalyst Downgrade3.39%CGONCG Oncology$75.01+0.4%2.4562 of 5 stars2.71$83.18 10.9%143.26%XENEXenon Pharmaceuticals$62.42-2.8%3.0234 of 5 stars3.00$77.13 23.6%17Insider TradeAnalyst Revision3.15%DNTHDianthus Therapeutics$116.08+5.9%1.9559 of 5 stars2.93$124.27 7.1%14Insider Trade3.14%ORKAOruka Therapeutics$111.12+2.8%3.1811 of 5 stars2.82$134.30 20.9%11News CoverageEarnings ReportAnalyst Forecast2.80%TVTXTravere Therapeutics$62.12+1.1%1.7657 of 5 stars2.69$61.67 -0.7%13Positive NewsAnalyst Revision2.56%DFTXDefinium Therapeutics$42.59-3.0%3.0394 of 5 stars3.00$62.14 45.9%18Trending NewsAnalyst ForecastAnalyst Revision2.39%ACADACADIA Pharmaceuticals$28.25-0.5%4.555 of 5 stars2.82$33.69 19.3%17Analyst Forecast2.36%MANEVeradermics$113.18+2.0%2.3771 of 5 stars2.67$153.00 35.2%9Earnings Report2.25%DYNDyne Therapeutics$25.74-0.8%3.7468 of 5 stars2.87$34.42 33.7%15Positive News2.23%EWTXEdgewise Therapeutics$44.18+2.3%2.1051 of 5 stars2.82$49.08 11.1%11Analyst Forecast2.22%RLAYRelay Therapeutics$19.84-0.5%3.3876 of 5 stars2.86$25.83 30.2%14Analyst Forecast1.97%DNLIDenali Therapeutics$24.42-1.6%2.7208 of 5 stars2.75$35.92 47.1%16News CoverageAnalyst Revision1.84%GPCRStructure Therapeutics$54.36-0.6%2.1319 of 5 stars2.89$110.91 104.0%18Analyst Revision1.75%NAMSNewAmsterdam Pharma$27.03+1.4%2.5678 of 5 stars2.93$49.33 82.5%141.69%MBXMBX Biosciences$68.68+2.4%2.294 of 5 stars2.75$75.63 10.1%121.68%IDYAIDEAYA Biosciences$36.31-1.0%2.6142 of 5 stars2.81$50.13 38.1%161.61%CLDXCelldex Therapeutics$41.93-1.6%2.9158 of 5 stars2.86$55.46 32.3%14Analyst Revision1.59%IRONDisc Medicine$78.82-1.5%2.6194 of 5 stars2.75$106.00 34.5%121.39%IMNMImmunome$27.18+2.9%2.8571 of 5 stars2.85$34.64 27.4%13Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision1.37%TARSTarsus Pharmaceuticals$69.28+0.6%3.0954 of 5 stars2.78$90.50 30.6%9Analyst ForecastAnalyst Revision1.29%NKTRNektar Therapeutics$72.90-4.0%2.8054 of 5 stars2.75$150.00 105.8%12Trending NewsEarnings ReportGap Down1.26%VCELVericel$44.27-0.6%4.3036 of 5 stars2.57$58.40 31.9%7Positive News1.24%VERAVera Therapeutics$31.65+9.5%3.0929 of 5 stars2.86$81.15 156.4%14Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading Volume This page (NYSEARCA:SBIO) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBarricks gold output fell from 2 million ounces to 719000Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...Golden Portfolio | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBIO Stock Alerts